Xbrane Biopharma: Ximluci Approved in the EU

Research Note

2022-11-11

09:43

Redeye leaves a short comment on today’s news that Xbrane and STADA have secured EU approval for Ximluci. Today’s announcement was expected, but it nevertheless marks a significant milestone for the company, and the Q1 2023 launch is nearing swiftly.

Filip Einarsson

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.